Published on
March 19, 2025
- 11:00 GMT
Modulo Bio Announces $4.8M Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)
Funds will help support the development of MOD 001, a neuroimmune system modulator SAN DIEGO, CA, UNITED STATES, March 19, 2025 /EINPresswire.com/ -- Modulo Bio, a company reprogramming the brain's immune system, announced today that it has received …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
